Clinical Trial Update: Study of DC-CIK to Treat NPC [Phase 2]

View source ↗

Summary

Ongoing Phase 2 clinical trial evaluating DC-CIK therapy for nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• DC-CIK therapy (dendritic cell-cytokine-induced killer cells)

Snippet

Sponsor: Guangxi Medical University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN